George Dangas, MD, PhD, MSCAI, Professor of Medicine (Cardiology), and Surgery, at the Icahn School of Medicine at Mount Sinai will serve as SCAI President for the 2023-2024 term. He is also Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute at Icahn Mount Sinai and Chief of Cardiology at Mount Sinai Queens, and the first Mount Sinai cardiologist to hold this position.
George Dangas, MD, PhD, MSCAI, Professor of Medicine (Cardiology), and Surgery, at the Icahn School of Medicine at Mount Sinai will serve as SCAI President for the 2023-2024 term. He is also Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute at Icahn Mount Sinai and Chief of Cardiology at Mount Sinai Queens, and the first Mount Sinai cardiologist to hold this position.
A novel 48-mm stent for the treatment of diffuse de novo coronary artery lesions was found to be safe and effective at 1 year, with a high level of device deliverability, a speaker reported.The results of the prospective, single-arm, open-label, multicenter global SPIRIT 48 trial were presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions and simultaneously